Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to -$35.6 million.

  • Abeona Therapeutics' Income towards Parent Company fell 1747.33% to -$35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.8 million, marking a year-over-year increase of 16761.36%. This contributed to the annual value of -$68.4 million for FY2024, which is 4387.95% down from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Income towards Parent Company is -$35.6 million, which was down 1747.33% from $108.8 million recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Income towards Parent Company high stood at $108.8 million for Q2 2025, and its period low was -$46.7 million during Q4 2021.
  • For the 5-year period, Abeona Therapeutics' Income towards Parent Company averaged around -$10.3 million, with its median value being -$15.2 million (2021).
  • Its Income towards Parent Company has fluctuated over the past 5 years, first crashed by 19485.09% in 2021, then surged by 136952.47% in 2025.
  • Abeona Therapeutics' Income towards Parent Company (Quarter) stood at -$46.7 million in 2021, then skyrocketed by 71.9% to -$13.1 million in 2022, then dropped by 1.56% to -$13.3 million in 2023, then plummeted by 33.31% to -$17.8 million in 2024, then plummeted by 100.28% to -$35.6 million in 2025.
  • Its last three reported values are -$35.6 million in Q3 2025, $108.8 million for Q2 2025, and -$20.7 million during Q1 2025.